• Direct care of patients
with myocardial infarction and assist in resuscitation / code blue situations • Oversee care of pre and post CABG (coronary artery bypass graft), pre and post cardiac cath, Angiogram / Angioplasty, AICD, PPM, acute stroke, and post-op peripheral vascular surgery patients • Perform EKG and telemetry monitoring, interpret results, and intervene as needed • Collaborates with physicians and social workers regarding discharge planning and follow up care plans • Educate patients and families about healthy living including smoking cessation, alcohol cessation, etc. • Set age - appropriate short - term and long term goals in care planning • Administer intravenous drugs, drips, and combinations drugs using 5 rights and titration of vasoactive drugs with the use of IV infusion pump
Interpreted EKGs for patients
with myocardial infarctions, chest pain, congestive heart failure, pulmonary emboli and other heart conditions.
We will explain what is involved
with a Myocardial..
Feline Tachyarrhythmia - Sustained tachyarrhythmias (rapid heartbeat faster than normal) are usually associated
with myocardial disease.
RESULTS: A total of 36,354 patients (33.9 %) claimed at least 1 prescription of an NSAID after discharge; 60,974 (56.9 %) died, and 8970 (8.4 %) and 39,984 (37.5 %) were hospitalized
with myocardial infarction or HF, respectively.
Objectives: The study goal was to leverage 3 distinct lines of evidence - a family that included individuals with complete (compound heterozygote) ANGPTL3 deficiency, a population based - study of humans with partial (heterozygote) ANGPTL3 deficiency, and biomarker levels in patients
with myocardial infarction (MI)- to test whether ANGPTL3 deficiency is associated with lower risk for CAD.
Heart Repair Using Nanogel - Encapsulated Human Cardiac Stem Cells in Mice and Pigs
with Myocardial Infarction.
My first post in 2015 was uncannily prescient: it reviewed a study that uncover rare variants associated
with myocardial infarction using exome data from NHLBI's Exome Sequencing Project (ESP).
With myocardial infarction injury,...
«In conclusion, the study by Carrero et al in this issue of JAMA provides the best evidence to date that vitamin K antagonists [anticoagulants] are associated with improved clinical outcomes and no significant increased risk of bleeding in patients
with myocardial infarction and atrial fibrillation with advanced CKD.»
Not exact matches
In March, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion to include a new indication for adults
with established atherosclerotic cardiovascular disease (
myocardial infarction, stroke or peripheral arterial disease) to reduce cardiovascular risk by lowering LDL - C levels.
Di Stéfano has had several health scares in recent years and underwent a quadruple aorta - coronary bypass
with a pacemaker implanted in December 2005 after suffering a
myocardial infarction.
Both a heart attack (
myocardial infarction or MI) and a sudden cardiac arrest have to do
with the heart, but they are different problems.
RESULTS: If observed associations between breastfeeding duration and maternal health are causal, we estimate that current breastfeeding rates result in 4,981 excess cases of breast cancer, 53,847 cases of hypertension, and 13,946 cases of
myocardial infarction compared
with a cohort of 1.88 million U.S. women who optimally breastfed.
Breastfeeding is also associated
with maternal health outcomes.5 Shorter duration of lactation is associated
with increased maternal breast cancer, 6 ovarian cancer, 7,8 hypertension, 9 — 11 type 2 diabetes mellitus, 9,12 and
myocardial infarction (MI).9, 13 We estimate the burden of maternal disease that might be averted if more mothers were able to adhere to infant feeding recommendations, assuming a causal association between breastfeeding and maternal health.
Before his death, Folkman began to explore treatments
with angiogenesis inhibitors for conditions as seemingly disparate as
myocardial infarction, diabetes, macular degeneration, and even obesity [4].
This resulted in increased basal
myocardial adenylyl cyclase activity, enhanced atrial contractility, and increased left ventricular function in vivo; these parameters at baseline in the transgenic animals were equal to those observed in control animals maximally stimulated
with isoproterenol.
His study, conducted
with U-M cardiologist Brahmajee Nallamothu, M.D., M.P.H. and team at the U-M Institute for Healthcare Policy and Innovation, looked at the type of stress test known as SPECT
myocardial perfusion imaging, which can use Tc - 99m or, less precisely, thallium - 201.
In patients undergoing transradial primary percutaneous coronary intervention (PCI) for ST elevation
myocardial infarction (STEMI), there was no significant difference in the rate of a composite of death,
myocardial infarction and stroke whether they were anticoagulated
with bivalirudin or unfractioned heparin, according to a study in JACC: Cardiovascular Interventions.
A number of factors were associated
with an increased risk of developing heart failure after a first
myocardial infarction.
Better control of inflammation
with biologic therapy might reduce not only the rate of heart attacks, but potentially also affect the size of
myocardial infarctions.»
«Rheumatologists can be reassured that treatment of active rheumatoid arthritis
with anti-TNF therapy may lead not just to an improvement in joint symptoms, but also a reduction in the rate of
myocardial infarctions in the medium term,» says Dr. Dixon
For the purpose of additional experiments, the researchers generated
myocardial cells from embryonic stem cells and human skin cells, in collaboration
with the lab headed by Prof Dr Jürgen Hescheler at the University of Cologne.
Data from the BRIGHT trial recently published in the Journal of the American Medical Association demonstrated that bivalirudin was superior to both heparin monotherapy and heparin plus tirofiban for patients
with acute
myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI).
Moreover, in collaboration
with Prof Dr Henrik Milting at the Heart and Diabetes Center in Bad Oeynhausen, the researchers from Bochum analysed isolated
myocardial cells from explanted hearts of patients.
High - sensitivity assays for cardiac troponin T can quickly and safely rule out
myocardial infarction (MI) in patients presenting to emergency departments (ED)
with possible emergency acute coronary syndrome.
The ICD Registry identifies an opportunity for the use of medical therapy for patients
with prior
myocardial infarction or left ventricular systolic dysfunction; nearly 25 percent of ICD patients did not receive optimal medical therapy
with ACE inhibitors and / or beta blockers at discharge.
A phase 2 trial showed a reduction in the combined outcome of death or
myocardial infarction (heart attack) in patients treated
with otamixaban compared
with unfractionated heparin (UFH) plus eptifibatide (an antiplatelet drug) and showed similar bleeding rates
with otamixaban at midrange doses.
The patients
with chest pain diagnoses were classified into 1 of 5 testing strategies: no noninvasive testing, exercise electrocardiography (EE, evaluates the heart's electrical activity), stress echocardiography (SE, ultrasound),
myocardial perfusion scintigraphy (MPS, scan of heart) or coronary computed tomography angiography (CCTA, CT imaging).
There have been continued improvements in meeting guideline - recommended Door - to - Balloon (D2B) times of 90 minutes or less for patients
with ST - segment elevation
myocardial infarction.
This study assessed the association of antidepressant prescription at hospital discharge
with the one - year outcomes of patients
with acute
myocardial infarction (heart attack).
OBTAIN (Outcomes of Beta - Blocker Therapy After
Myocardial Infarction) is an observational multicenter registry in which beta - blocker dosing information was collected in patients
with an acute heart attack at participating centers to assess the effect of dose on survival.
The primary outcome of death or new
myocardial infarction through day 7 occurred in 5.5 percent of the patients treated
with otamixaban vs. 5.7 percent of the patients treated
with UFH plus eptifibatide.
Frits R. Rosendaal, M.D., Ph.D., of Leiden University Medical Center, the Netherlands, and coauthors determined long - term mortality and morbidity in young women who survived
myocardial infarction (heart attack) or ischemic stroke compared
with a control group.
Psychiatric illness was already known to be highly comorbid — existing at the same time as another medical condition —
with heart failure, acute
myocardial infarction (AMI) and pneumonia.
The FDA's medical reviewer's recommendation for approval says, in part, that more trials before approval would «significantly delay effective therapy,» which not only reduces body weight but exerts favorable effects on blood pressure and
myocardial oxygen for «patients
with a serious disease condition
with few treatment options.»
Furthermore, when the authors examined the outcomes individually, the OSA risk factors were associated
with increased risk for all - cause mortality, hospitalization for congestive heart failure, and stroke, but not for acute
myocardial infarction.
For example aspirin reduces the risk of stroke but does not affect the occurrence of
myocardial infarction in women, while in men aspirin reduces the risk of
myocardial infarction
with a non-significant increase in the risk of stroke.
Co-authors
with Halade of the paper «Immune responsive resolvin D1 programs
myocardial infarction - induced cardiorenal syndrome in heart failure» are Vasundhara Kain, Ph.D., UAB Department of Medicine; and Charles N. Serhan, Ph.D., Brigham and Women's Hospital and Harvard Medical School, Boston.
«We first established that marathon related segmental function decrease — observed in more than half of all segments — is associated
with a decrease in resting perfusion and increase in
myocardial edema,» observes senior author Eric Larose, DVM, MD, FRCPC, FAHA, of the Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ), Canada.
«Based on the results seen
with ADRCs in the PRECISE trial, we designed ATHENA to look at these cells as a possible treatment option for people
with refractory chronic
myocardial ischemia.»
Dr. Henry presented «Final Results for THE ATHENA TRIALS: Autologous Adipose Derived Regenerative Cells (ADRCs) for Refractory Chronic
Myocardial Ischemia
with Left Ventricular (LV) Dysfunction» on Thursday, May 5, 2016 at 11:00 a.m. ET.
The researchers analyzed data on more than 69,000 black and white patients
with acute
myocardial infarction (AMI) treated at 253 hospitals in three states during 2006 - 07.
One non-Q-wave
myocardial infarction occurred,
with a nine - month target lesion failure rate of 2.1 %.
Previous history of
myocardial infarction within 1 year prior to study entry, uncontrolled hypertension or uncontrolled arrhythmias • Pulmonary disease (e.g. COPD, asthma, etc) that is not controlled (moderate to severe symptoms)
with current medication • Active, uncontrolled bacterial, viral, or fungal infections, requiring systemic therapy
A comparison of both DENSE and feature tracking techniques
with tagging for the cardiovascular magnetic resonance assessment of
myocardial strain
Analysis of a linkage peak on chromosome 13
with a dense set of SNPs (single nucleotide polymorphisms) revealed a four - SNP haplotype spanning the gene encoding FLAP (ALOX5AP) that confers an approximately twofold increased risk of
myocardial infarction, or heart attack.
Encapsulation allows for diffusion of pro-angiogenic cytokines and growth factors made by the hMSCs while maintaining them at the site of implantationâ $ ¦ Alginate encapsulated hMSCs attached to the heart
with a hydrogel patch resulted in a highly significant improvement in left ventricular function after acute
myocardial infarction.
Per standard deviation increases in BPA concentration were associated
with positive responses to questions about physician diagnoses of
myocardial infarction in age, sex and ethnicity adjusted models in 2005/06 (OR = 1.31, 95 % CI: 1.02 to 1.68, p = 0.036),
with OR estimates for reported angina and «coronary heart disease» being similar to 2003/04 but narrowly missing conventional two sided statistical significance (Table 2).
The paper, entitled «The gene encoding 5 - lipoxygenase activating protein confers risk of
myocardial infarction and stroke,» presents the results of a major population study of heart attack linking a version of the gene encoding FLAP
with a nearly twofold increased risk of heart attack.